MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

SJ. Kim (Busan, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1692

Keywords: Cognitive dysfunction

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: The Seoul-instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, the cutoff point of S-iADL was also determined from patients, who were constituted from most of Alzheimer disease and other dementia patients. Although S-iADL has never been validated in Parkinson disease dementia (PDD), this scale has been used for diagnosis of PDD in Korea. The aim of this study is to identify cutoff score of S-iADL for differentiation of PDD from PD with normal cognition (PD-NC) and PD with mild cognitive impairment (PD-MCI).

Background: In diagnosis of PDD, dementia symptoms with insidious onset and slow progression ought to reveal in at least two of the four core cognitive domains and it has to be severe enough to impair daily life, which must be independent from motor or autonomic dysfunctions. However, there is no exact recommendation how to evaluate ADL in PDD patients.

Method: Newly diagnosed PD patients was divided into two subgroups as follows: PD-NC and PD-MCI (n=114) versus PDD (n=13). Clinical diagnosis of PDD was defined by suggestions of the MDS-Task Force team. We obtained age at registration, age at onset, education, gender, disease duration, S-iADL, Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), Clinical Dementia Rating (CDR), CDR-sum of box (CDR-SOB), initial motor Unified Parkinson’s Disease Rating Scale (mUPDRS) and Hoehn-Yahr (HY) stage.

Results: mUPDRS (p=0.036), HY stage (p=0.025), MMSE z-score (p=0.002), MoCA (p=0.002) and CDR (p=0.018) shows significant differences between PD-NC plus PD-MCI and PDD. Cutoff point of S-iADL was over 1.0. For diagnosing PDD, S-iADL showed that 80% of sensitivity, 82.93 % of specificity, 36.4% of positive predictive value (PPV), and 97.1% of negative predictive value (NPV). PDD was not correlated with S-iADL, but MMSE z-score, CDR and CDR-SOB are associated with PDD.

Conclusion: S-iADL shows an limitation to diagnose PDD from PD-NC and PD-MCI. Interesting point in this study, PDD is more correlated with CDR and CDR-SOB than S-iADL. In addition, MMSE z-score and MoCA are also well associated with PDD. Therefore, it needs to have another good ADL scale, not S-iADL, in the future.

To cite this abstract in AMA style:

SJ. Kim. Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/validation-of-the-seoul-instrumental-activity-daily-living-in-the-detection-of-dementia-in-parkinson-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-the-seoul-instrumental-activity-daily-living-in-the-detection-of-dementia-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley